miR-19b controls cardiac fibroblast proliferation and migration

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 6, 2016, Pages 1191-1197

  Zhong, Chongjun ^a   Wang, Kun ^a   Liu, Ying ^b   Lv, Dongchao ^c   Zheng, Bo ^d   Zhou, Qiulian ^c   Sun, Qi ^c   Chen, Ping ^c   Ding, Shengguang ^a   Xu, Yiming ^a   Huang, Haitao ^a  

^a NANTONG UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c SHANGHAI UNIVERSITY   (China)

^d Shanghai Institute of Biological Products Co Ltd   (China)

Author keywords

Cardiac fibrosis; MiR 19b; Pten

Indexed keywords

COLLAGEN TYPE 1; MICRORNA; MICRORNA 19B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; MIRN19 MICRORNA, RAT;

ANIMAL CELL; CELL ISOLATION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HEART FIBROBLAST; NEWBORN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; CELL MOTION; CYTOLOGY; FIBROBLAST; GENETICS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; MICRORNAS; MYOCARDIUM; PTEN PHOSPHOHYDROLASE; RATS, SPRAGUE-DAWLEY;

EID: 84970024035     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12858     Document Type: Note

References (34)

1. Zhou Y, Deng L, Zhao D, et al. MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13. J Cell Mol Med. 2016; 20: 495-505.
2. Zeigler AC, Richardson WJ, Holmes JW, et al. Computational modeling of cardiac fibroblasts and fibrosis. J Mol Cell Cardiol. 2015;. doi:10.1016/j.yjmcc.2015.11.020.
3. Tao H, Shi KH, Yang JJ, et al. Epigenetic regulation of cardiac fibrosis. Cell Signal. 2013; 25: 1932-8.
4. Tijsen AJ, van der Made I, van den Hoogenhof MM, et al. The microRNA-15 family inhibits the TGFbeta-pathway in the heart. Cardiovasc Res. 2014; 104: 61-71.
5. Jiang X, Tsitsiou E, Herrick SE, et al. MicroRNAs and the regulation of fibrosis. FEBS J. 2010; 277: 2015-21.
6. Dai Y, Khaidakov M, Wang X, et al. MicroRNAs involved in the regulation of postischemic cardiac fibrosis. Hypertension. 2013; 61: 751-6.
7. van Putten S, Shafieyan Y, Hinz B. Mechanical control of cardiac myofibroblasts. J Mol Cell Cardiol. 2015; doi:10.1016/j.yjmcc.2015.11.025.
8. Zhao X, Wang K, Liao Y, et al. MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFbetaRI on cardiac fibroblasts. Cell Physiol Biochem. 2015; 35: 213-26.
9. Bei Y, Song Y, Wang F, et al. miR-382 targeting PTEN-Akt axis promotes liver regeneration. Oncotarget. 2016; 7: 1584-97.
10. Xu T, Zhou Q, Che L, et al. Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients. Oncotarget. 2016; doi:10.18632/oncotarget.6966.
11. Xiao J, Bei Y, Liu J, et al. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21. J Cell Mol Med. 2016; 20: 204-16.
12. Wang H, Bei Y, Shi J, et al. Non-coding RNAs in cardiac aging. Cell Physiol Biochem. 2015; 36: 1679-87.
13. Tao L, Bei Y, Zhou Y, et al. Non-coding RNAs in cardiac regeneration. Oncotarget. 2015; 6: 42613-22.
14. Melman YF, Shah R, Danielson K, et al. Circulating MicroRNA-30d Is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a Translational Pilot Study. Circulation. 2015; 131: 2202-16.
15. Lv D, Liu J, Zhao C, et al. Targeting microRNAs in pathological hypertrophy and cardiac failure. Mini Rev Med Chem. 2015; 15: 475-8.
16. Liu X, Xiao J, Zhu H, et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015; 21: 584-95.
17. Liang D, Xu X, Deng F, et al. miRNA-940 reduction contributes to human Tetralogy of Fallot development. J Cell Mol Med. 2014; 18: 1830-9.
18. Xiao J, Liang D, Zhang H, et al. MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J Mol Cell Cardiol. 2012; 53: 751-9.
19. Mai L, Xiao L, Huang Y, et al. Novel microRNAs involved in regulation of cardiac fibrosis. Int J Cardiol. 2015; 192: 14-5.
20. Tao H, Yang JJ, Hu W, et al. Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead. Pflugers Arch. 2016; doi:10.1007/s00424-016-1792-y.
21. Wang X, Liu T, Zhao Z, et al. Noncoding RNA in cardiac fibrosis. Int J Cardiol. 2015; 187: 365-8.
22. van Almen GC, Verhesen W, van Leeuwen RE, et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. 2011; 10: 769-79.
23. Danielson LS, Park DS, Rotllan N, et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 2013; 27: 1460-7.
24. Chen J, Huang ZP, Seok HY, et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res. 2013; 112: 1557-66.
25. Mogilyansky E, Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013; 20: 1603-14.
26. Qin DN, Qian L, Hu DL, et al. Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/beta-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro. Cell Biochem Biophys. 2013; 66: 709-22.
27. Xu JH, Tang Y, Bei YH, et al. miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN. Oncotarget. 2016; doi:10.18632/oncotarget.7678.
28. Tao H, Yang JJ, Shi KH, et al. Wnt signaling pathway in cardiac fibrosis: new insights and directions. Metabolism. 2016; 65: 30-40.
29. Sun M, Yu H, Zhang Y, et al. MicroRNA-214 mediates isoproterenol-induced proliferation and collagen synthesis in cardiac fibroblasts. Sci Rep. 2015; 5: 18351.
30. Moore-Morris T, Cattaneo P, Puceat M, et al. Origins of cardiac fibroblasts. J Mol Cell Cardiol. 2015; 91: 1-5.
31. Wijnen WJ, Pinto YM, Creemers EE. The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand? J Cardiovasc Transl Res. 2013; 6: 899-908.
32. Orenes-Pinero E, Montoro-Garcia S, Patel JV, et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol. 2013; 167: 1651-9.
33. Lakner AM, Steuerwald NM, Walling TL, et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology. 2012; 56: 300-10.
34. Ge SF, Xie JP, Liu F, et al. MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis model in vivo and in vitro as part of the inhibitory effects of estradiol. J Cell Biochem. 2015; 116: 2455-64.